Susan ("Suzie") Riley
About Susan ("Suzie") Riley
Susan 'Suzie' Riley is a Principal Scientist specializing in R&D and Product Development at Organogenesis, where she has worked since 2018. She holds a Ph.D. in Chemical Engineering and has extensive experience in regenerative medicine, focusing on bioreactor systems and biomaterials.
Work at Organogenesis
Currently, Susan Riley holds the position of Principal Scientist in R&D and Product Development at Organogenesis, a role she has occupied since 2020. Prior to this, she served as a Senior Scientist in Product Development from 2018. Her tenure at Organogenesis began with a position as Senior Scientist in Process Development from 2014 to 2015. All her roles at Organogenesis have been based in La Jolla, CA.
Previous Employment History
Susan Riley has a diverse background in the biotechnology and pharmaceutical industries. She worked at Advanced BioHealing, Inc. as a Senior Scientist in Research from 2010 to 2011. Prior to that, she spent six years at Cytori Therapeutics as a Senior Scientist and Sr. Manager of Development from 2003 to 2009. She also held the position of Manager of Polymer Research at Macropore Biosurgery Inc. from 2003 to 2006. Additionally, she worked at Shire Pharmaceuticals as a Senior Scientist in Process Development from 2011 to 2014 and briefly served as a Senior Science Consultant at NuVasive in 2010. Her role at Vital Therapies, Inc. as Principal Scientist in Analytical Development lasted from 2015 to 2018.
Education and Expertise
Susan Riley earned her Ph.D. in Chemical Engineering from Rice University, specializing in Regenerative Medicine and Tissue Engineering. She also holds a B.S. in Chemical Engineering from the University of Minnesota. Her educational background supports her expertise in the design and development of closed bioreactor systems, analytical and mechanical characterization of polymers, and the interaction of biomaterials with cells and tissue.
Specialized Skills
Susan Riley possesses specialized skills in factorial study designs (DOEs), which are essential for optimizing experimental conditions in product development. She utilizes Six Sigma methodologies to enhance process efficiency and product quality, particularly in the field of regenerative medicine. Her expertise in the interaction of biomaterials with cells and tissue is crucial for developing advanced regenerative therapies.